Last reviewed · How we verify
C.B. Fleet Company, Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
3 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Gastroenterology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ahmed M Maged, MD · 1 shared drug class
- Amsterdam UMC, location VUmc · 1 shared drug class
- Azienda Policlinico Umberto I · 1 shared drug class
- Bayer · 1 shared drug class
- Benaroya Research Institute · 1 shared drug class
- Bo-In Lee · 1 shared drug class
- Braintree Laboratories · 1 shared drug class
- Aboca Spa Societa' Agricola · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for C.B. Fleet Company, Inc.:
- C.B. Fleet Company, Inc. pipeline updates — RSS
- C.B. Fleet Company, Inc. pipeline updates — Atom
- C.B. Fleet Company, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). C.B. Fleet Company, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/c-b-fleet-company-inc. Accessed 2026-05-17.